Astragen Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 17-07-2024
- Paid Up Capital ₹ 4.00 M
as on 17-07-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.97 Cr
as on 17-07-2024
- Satisfied Charges ₹ 8.70 M
as on 17-07-2024
- Revenue 7.45%
(FY 2023)
- Profit 35.07%
(FY 2023)
- Ebitda 6.33%
(FY 2023)
- Net Worth 7.09%
(FY 2023)
- Total Assets -29.31%
(FY 2023)
About Astragen Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹2.97 Cr. The company has closed loans amounting to ₹8.70 M, as per Ministry of Corporate Affairs (MCA) records.
Anjusha Putchakayala, Padma Putchakayala, and Jagadeeswara Putchakayala serve as directors at the Company.
- CIN/LLPIN
U24232TG2007PTC053448
- Company No.
053448
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Apr 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Astragen Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagadeeswara Putchakayala  | Managing Director | 03-Apr-2007 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anjusha Putchakayala | Director | 23-Dec-2017 | Current |
| Padma Putchakayala | Director | 03-Apr-2007 | Current |
Financial Performance of Astragen Laboratories.
Astragen Laboratories Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.45% increase. The company also saw a substantial improvement in profitability, with a 35.07% increase in profit. The company's net worth moved up by a moderate rise of 7.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Astragen Laboratories?
In 2023, Astragen Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anjusha Reddy Studio (Opc) Private LimitedActive 2 years 6 monthsAnjusha Putchakayala is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 07 Sep 2020 | ₹2.97 Cr | Open |
Others Creation Date: 28 Jan 2008 | ₹8.70 M | Satisfied |
How Many Employees Work at Astragen Laboratories?
Unlock and access historical data on people associated with Astragen Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Astragen Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astragen Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
